MTF Biologics Appoints Donald Hackbarth and Sharon Gabrielson to Key Leadership Roles on Board of Directors
Industry Leaders Bring Extensive Expertise to Advance MTF Biologics’ Mission of Honoring…
Predictive Oncology Closes Registered Direct Offering
February 19, 2025 17:20 ET | Source: Predictive Oncology Inc. PITTSBURGH, Feb.…
Biologics Conference 2025 Concludes Successfully, Setting New Benchmarks in Biopharmaceutical Innovation and Collaboration
MUMBAI, India, Feb. 14, 2025 /PRNewswire/ -- The Institute of Chemical Technology, Mumbai,…
VJ Biosciences Debuts at 5th Annual Summit of Biologics Conferences with a Bold Vision for Biopharmaceutical Innovation
BANGALORE, India, Feb. 3, 2025 /PRNewswire/ -- New York-based VJ Group announced…
Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand
Mails Letter to Stockholders Highlighting the Significant, Immediate and Certain Cash Value…
Almirall at the JPMorgan Conference – Entering a New Era of Sustained Growth
Almirall's unique dedication to medical dermatology and innovation - combined with its…
Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Application based on TROPION-Lung05 phase 2 trial and supported by data from…
Telix Files TLX250-CDx (Zircaix) BLA for Kidney Cancer Imaging
December 29, 2024 16:53 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia…
BullFrog AI Issues Letter to Stockholders
December 27, 2024 08:00 ET | Source: BullFrog AI Holdings, Inc. GAITHERSBURG,…
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
Files Definitive Proxy Statement and Mails Letter to Stockholders December 18, 2024…